XML 25 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues:      
Premiums $ 99,192 $ 85,330 $ 76,132
Net investment income 1,153 838 1,199
Total revenues 357,776 322,467 292,111 Close
Operating costs:      
Cost of products sold 217,098 196,892 175,803
Health care costs 86,247 71,073 64,188
Restructuring charges 507 0 0
Opioid litigation charges 0 5,803 0
Loss on assets held for sale 349 2,533 0
Store impairments 0 0 1,358
Goodwill impairment 0 0 431
Operating expenses 39,832 38,212 37,021
Total operating costs 344,033 314,513 278,801 Close
Operating income 13,743 7,954 13,310 Close
Interest expense 2,658 2,287 2,503 Close
Loss on early extinguishment of debt 0 0 452 Close
Other income (88) (169) (182) CloseClose
Total Other Income Expenses 2570.0 2118.0 2773.0 0.0 0 Close
Income before income tax provision 11,173 5,836 10,537 CloseClose
Income tax provision 2,805 1,509 2,548 Close
Net income 8,368 4,327 7,989 Close
Net (income) loss attributable to noncontrolling interests (24) (16) 12
Net income attributable to CVS Health $ 8,344 $ 4,311 $ 8,001
Net income per share attributable to CVS Health:      
Basic (in dollars per share) $ 6.49 $ 3.29 $ 6.07
Diluted (in dollars per share) $ 6.47 $ 3.26 $ 6.02
Weighted average shares outstanding:      
Basic (in shares) 1,285 1,312 1,319
Diluted (in shares) 1,290 1,323 1,329
Dividends declared per share (in dollars per share) $ 2.42 $ 2.20 $ 2.00
Cost, Product and Service [Extensible List] Products Products Products
Products      
Revenues:      
Revenues $ 245,138 $ 226,616 $ 203,738
Services      
Revenues:      
Revenues $ 12,293 $ 9,683 $ 11,042